先天性副腎過形成症患者を対象としたクロノコートの長期安全性試験

基本情報

NCT ID: NCT05299554
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 76
治験依頼者名: Neurocrine UK Limited

概要

This phase III study is an open-label extension study to be conducted at approximately 21 investigational sites across 3 countries. The study will evaluate the long-term safety and tolerability of Chronocort in participants aged 16 years and over when used as treatment for Congenital Adrenal Hyperplasia (CAH).

対象疾患

先天性副腎過形成

介入

Chronocort(DRUG)

依頼者（Sponsor）

Neurocrine Uk Limited(INDUSTRY)

実施施設 (4)

Neurocrine Investigational Site in Toyama

Shinjuku-Ku, Tokyo, Japan

Neurocrine Investigational Site in Okura

Setagaya-Ku, Tokyo, Japan

Neurocrine Investigational Site in Asahi-ku

Yokohama, Kanagawa, Japan

Neurocrine Investigational Site in Yushima

Bunkyō-Ku, Tokyo, Japan